Peter A. Thompson Transaction History

Date Transaction Value Shares Traded Form
May 18 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
2,680,496
Jan 11 2024
BUY
Exercise of in-the-money or at-the-money derivatives securities
$1,850,497 $12.74 p/Share
145,251
Dec 28 2023
SELL
Open market or private sale
$26,027,670 $19.07 p/Share
1,364,849
Dec 27 2023
SELL
Open market or private sale
$3,622,700 $19.96 p/Share
181,498
Sep 17 2021
BUY
Open market or private purchase
$9,499,987 $9.4 p/Share
1,010,637
Dec 28 2020
SELL
Open market or private sale
$8,550,000 $14.25 p/Share
600,000

Also insider at

SBTX
Silverback Therapeutics, Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
DBTX
Decibel Therapeutics, Inc. Healthcare
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
PMVP
PMV Pharmaceuticals, Inc. Healthcare
JANX
Janux Therapeutics, Inc. Healthcare
PAT

Peter A. Thompson

Director
Burlingame, CA

Track Institutional and Insider Activities on ALPN

Follow ALPINE IMMUNE SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALPN shares.

Notify only if

Insider Trading

Get notified when an Alpine Immune Sciences, Inc. insider buys or sells ALPN shares.

Notify only if

News

Receive news related to ALPINE IMMUNE SCIENCES, INC.

Track Activities on ALPN